Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Sonoelastography: Ultrasound Method to Measure Liver Fibrosis [NA]
A completed clinical trial evaluated sonoelastography, an ultrasound method to measure liver fibrosis; results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-06-02Clinical Trial Update: Dose Ranging of GSK2336805 in Combination Therapy [Phase 2]
Phase 2 dose-ranging study of GSK2336805 in combination therapy for chronic hepatitis C was completed, with results posted in June 2017.
-
CLINICAL_TRIALS trial_result · 2017-06-01Clinical Trial Update: Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV)-1 Coinfection [Phase 3]
Phase 3 trial evaluating the efficacy and safety of sofosbuvir/velpatasvir fixed-dose combination for 12 weeks in adults with chronic HCV an…
-
CLINICAL_TRIALS trial_result · 2017-06-01Clinical Trial Update: Curing HCV in Incarcerated Patients [Phase 4]
Phase 4 clinical trial update investigating cure of hepatitis C in incarcerated individuals; status of the trial is currently unknown.
-
CLINICAL_TRIALS research · 2017-05-31Clinical Trial Update: Epidemiology of Hepatitis C Virus Infection Among Opioid Substituted Patients
This entry describes an observational epidemiology study on hepatitis C virus infection among patients receiving opioid substitution therapy…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2017-05-30Clinical Trial Update: Pattern of Skin Manifestations in Chronic Hepatitis c Virus Patients Before and After Direct Acting Anti Viral Drugs
This clinical trial investigates how skin manifestations in chronic hepatitis C patients change before and after treatment with direct-actin…
-
CLINICAL_TRIALS trial_result · 2017-05-25Clinical Trial Update: Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 or 24 Weeks in Genotype 1 or 4 HCV Infected Adults With Sickle Cell Disease [Phase 2]
Phase 2 trial evaluating fixed-dose Ledipasvir/Sofosbuvir for 12 or 24 weeks in adults with Hepatitis C infection and sickle cell disease; r…
-
CLINICAL_TRIALS research · 2017-05-25Clinical Trial Update: Hepatitis c and Vitamin D and Iron Status
This clinical trial update reports an ongoing study on Hepatitis C investigating vitamin D and iron status in participants.
-
CLINICAL_TRIALS trial_result · 2017-05-22Clinical Trial Update: Trial of Citalopram for the Prevention of Depression [Phase 3]
Phase 3 trial assessing whether citalopram can prevent depression in individuals with HIV infection or Hepatitis C; the study has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-22Clinical Trial Update: A Study of Combination Treatment With Peginterferon Alfa-2a (Pegasys) Plus Ribavirin (Copegus) in Participants With Chronic Hepatitis C [Phase 4]
A Phase 4 study evaluating the combination of Pegasys (peginterferon alfa-2a) and Copegus (ribavirin) in chronic hepatitis C has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-18Clinical Trial Update: Program of Screening, Prevention and Elimination of Hepatitis C in Penitentiary Institutions in Cantabria (JAILFREE-C) [Phase 4]
A Phase 4 clinical trial program called JAILFREE-C aiming to screen, prevent, and eliminate Hepatitis C in Cantabria's penitentiary institut…
-
CLINICAL_TRIALS trial_result · 2017-05-16Clinical Trial Update: Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection [Phase 4]
Phase 4 trial evaluating Anti-D (Rho(D) immune globulin) for thrombocytopenia in adults with hepatitis C with or without HIV infection; the …
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: Ombitasvir/ABT-450/Ritonavir and Dasabuvir Therapy With Low Dose Ribavirin (RBV), Full Dose RBV or RBV Add-On in Treatment Naive Genotype 1a Hepatitis C Virus Infected Adults [Phase 2]
Phase 2 trial assessing Ombitasvir/Paritaprevir/ritonavir plus Dasabuvir with low-dose, full-dose, or add-on ribavirin in treatment-naive ge…
-
CLINICAL_TRIALS withdrawal · 2017-05-12Clinical Trial Update: Triple Combination DAAs for Treating HCV GT1b Subjects [Phase 2]
A Phase 2 trial evaluating a triple direct-acting antiviral regimen for chronic hepatitis C infection (genotype 1b) has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-05-11Clinical Trial Update: Transient Elastography to Assess Liver Fibrosis and Portal Hypertension in HCV Cirrhotic Patients Treated With New Antiviral Drugs (SPLEEN-C) [NA]
A completed clinical trial (SPLEEN-C) evaluating transient elastography to measure liver fibrosis and portal hypertension in patients with c…
-
CLINICAL_TRIALS trial_result · 2017-05-11Clinical Trial Update: Hepatitis C Virus Infection in Patients With Hemoglobinopathies
A completed clinical trial update regarding Hepatitis C infection in patients with hemoglobinopathies.
-
CLINICAL_TRIALS trial_result · 2017-05-10Clinical Trial Update: Safety and Efficacy of Ledipasvir/Sofosbuvir in Adults With Chronic HCV Infection [Phase 3]
A Phase 3 trial evaluating the safety and efficacy of ledipasvir/sofosbuvir in adults with chronic hepatitis C virus infection has completed…
-
CLINICAL_TRIALS withdrawal · 2017-05-09Clinical Trial Update: Peginterferon and Ribavirin, With or Without Telaprevir, for Genotype 1 Hepatitis C and IL28B CC Polymorphism [Phase 4]
A Phase 4 trial evaluating peginterferon alfa-2a and ribavirin with or without telaprevir for genotype 1 Hepatitis C (IL28B CC polymorphism)…
-
CLINICAL_TRIALS trial_result · 2017-05-05Clinical Trial Update: Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic Genotype 1 or 4 HCV for Use in the Peri-Operative Liver Transplantation Setting [Phase 2]
Phase 2 trial assessing safety and efficacy of Ledipasvir/Sofosbuvir fixed-dose combination in patients with chronic genotype 1 or 4 HCV for…
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection [Phase 3]
Phase 3 trial update for the fixed-dose combination Sofosbuvir/Velpatasvir in adults with chronic hepatitis C virus infection.
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Asunaprevir/Daclatasvir Safety Surveillance in Japanese Patients With Chronic Hepatitis C
A completed safety surveillance study of the hepatitis C drug combination asunaprevir and daclatasvir in Japanese patients with chronic hepa…
-
CLINICAL_TRIALS trial_result · 2017-05-02Clinical Trial Update: Intervention to Improve HCV Treatment Uptake and Adherence in HIV/HCV Coinfection [NA]
A completed clinical trial assessing an intervention to improve uptake and adherence to hepatitis C treatment in individuals co-infected wit…
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: Early Treatment of Recurrent HCV- Infection Post Liver Transplantation in the Era of DAAs [Phase 4]
Phase 4 study evaluating early treatment of recurrent hepatitis C infection after liver transplantation using direct-acting antivirals; the …
-
CLINICAL_TRIALS withdrawal · 2017-04-28Clinical Trial Update: The Effects of Adding TCM-700C on the Standard Combination Treatment for HCV Genotype 1 Patients(Phase III) [Phase 3]
A Phase 3 trial evaluating adding TCM-700C to standard therapy for hepatitis C genotype 1 was withdrawn from the study. No results were repo…
-
CLINICAL_TRIALS trial_result · 2017-04-27Clinical Trial Update: Study to Determine the Effectiveness and Safety of a Three Drug Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Not Previously Treated With Currently Available Medications [Phase 2]
This Clinical Trial Update reports results from a Phase 2 study evaluating the safety and effectiveness of a three-drug antiviral combinatio…